tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market

Immunome (IMNM) Ownership - Who Owns Immunome?

Compare
301 Followers

Immunome (IMNM) Ownership Overview

1.62%22.65%41.54%10.54%23.65%
41.54% Other Institutional Investors
10.54% ETFs
23.65% Public Companies and Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 74.73% of the company’s stock is owned by Institutional Investors, 1.62% is owned by Insiders, and 23.65% is owned by Public Companies and Individual Investors.
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 64.19% of the company’s stock is owned by Institutional Investors, 1.62% is owned by Insiders, and 10.54% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 03, 2025
xxxxxxxxxxxxx
$46900
Mar 26, 2025
xxxxxxxxxxxxx
$60684
Mar 26, 2025
xxxxxxxxxxxxx
$999459
Mar 25, 2025
xxxxxxxxxxxxx
$57470

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$95323
Mar 31, 2025
xxxxxxxxxxxxx
$4109008
Mar 31, 2025
xxxxxxxxxxxxx
$11156516
Mar 31, 2025
xxxxxxxxxxxxx
$22974201

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,065,476Institution4.67%37,402,379
3,416,792Institution3.93%31,434,486
3,413,700Institution3.92%31,406,040
3,072,000Institution3.53%28,262,400
2,919,413Institution3.36%26,858,600
2,851,542Institution3.28%26,234,186
2,278,596Institution2.62%20,963,083
1,922,933Institution2.21%17,690,984
1,657,729Institution1.91%15,251,107
1,526,901Institution1.75%14,047,489

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,416,792Institution3.93%31,434,486
3,072,000Institution3.53%28,262,400
2,851,542Institution3.28%26,234,186
2,278,596Institution2.62%20,963,083
1,922,933Institution2.21%17,690,984
1,526,901Institution1.75%14,047,489
818,181Institution0.94%7,527,265
704,518Institution0.81%6,481,566
679,813Institution0.78%6,254,280
563,852Institution0.65%5,187,438

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,242,522Institution2.58%19,711,768
1,807,655Institution2.08%16,630,426
1,193,859Institution1.37%10,494,021
1,122,467Institution1.29%10,988,952
607,372Institution0.70%5,587,822
375,275Institution0.43%3,673,942
354,754Institution0.41%3,118,288
204,856Institution0.24%1,800,684
143,911Institution0.17%1,323,981
122,385Institution0.14%1,125,942

FAQ

Who Owns Immunome (IMNM)?
According to the latest TipRanks data, approximately 41.54% of the company's stock is held by institutional investors, 1.62% is held by insiders, and 23.65% is held by retail investors.
    What percentage of Immunome (IMNM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 41.54% of Immunome (IMNM) stock is held by institutional investors.
      What percentage of Immunome (IMNM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 23.65% of Immunome (IMNM) stock is held by retail investors.
        Who owns the most shares of Immunome (IMNM)?
        Vanguard owns the most shares of Immunome (IMNM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis